Zuckerman Investment Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-80,000
| Closed | -$328K | – | 121 |
|
|
2022
Q1 | $328K | Hold |
80,000
| – | – | 0.05% | 87 |
|
|
2021
Q4 | $286K | Hold |
80,000
| – | – | 0.04% | 92 |
|
|
2021
Q3 | $291K | Hold |
80,000
| – | – | 0.05% | 95 |
|
|
2021
Q2 | $349K | Hold |
80,000
| – | – | 0.06% | 92 |
|
|
2021
Q1 | $329K | Sell |
80,000
-20,000
| -20% | -$86.7K | 0.05% | 88 |
|
|
2020
Q4 | $399K | Hold |
100,000
| – | – | 0.07% | 67 |
|
|
2020
Q3 | $270K | Hold |
100,000
| – | – | 0.06% | 67 |
|
|
2020
Q2 | $275K | Hold |
100,000
| – | – | 0.07% | 67 |
|
|
2020
Q1 | $236K | Buy |
+100,000
| New | +$340K | 0.07% | 60 |
|
|
2019
Q4 | – | Sell |
-100,000
| Closed | -$334K | – | 72 |
|
|
2019
Q3 | $334K | Hold |
100,000
| – | – | 0.08% | 54 |
|
|
2019
Q2 | $329K | Hold |
100,000
| – | – | 0.07% | 56 |
|
|
2019
Q1 | $303K | Hold |
100,000
| – | – | 0.07% | 55 |
|
|
2018
Q4 | $272K | Hold |
100,000
| – | – | 0.08% | 51 |
|
|
2018
Q3 | $336K | Hold |
100,000
| – | – | 0.07% | 50 |
|
|
2018
Q2 | $258K | Buy |
+100,000
| New | +$249K | 0.06% | 53 |
|
Other funds holding ATRS
Zuckerman Investment Group's ATRS Position: Q2 2022 in Review
Zuckerman Investment Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 80,000 shares — an estimated $328K sold.
Zuckerman Investment Group first reported a position in ATRS in Q2 2018 and held it in 15 quarters. The position peaked at $399K in Q4 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Zuckerman Investment Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Zuckerman Investment Group sold 80,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $328K.
- Zuckerman Investment Group first reported a position in Antares Pharma, Inc. in Q2 2018 and held it in 15 quarters.
- Zuckerman Investment Group's Antares Pharma, Inc. position peaked at $399K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Zuckerman Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.